[Federal Register Volume 62, Number 114 (Friday, June 13, 1997)]
[Notices]
[Page 32373]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-15455]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Application
Pursuant to Section 1301.43(a) of Title 21 of the Code of Federal
Regulations (CFR), this is notice that on April 16, 1997, Penick
Corporation, 158 Mount Olivet Avenue, Newark, New Jersey 07114, made
application by renewal to the Drug Enforcement Administration (DEA) for
registration as a bulk manufacturer of the basic classes of controlled
substances listed below:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Tetrahydrocannabinols (7370)................ I
Dihydromorphine (9145)...................... I
Pholcodine (9314)........................... I
Cocaine (9041).............................. II
Codeine (9050).............................. II
Dihydrocodeine (9120)....................... II
Oxycodone (9143)............................ II
Hydromorphone (9150)........................ II
Diphenoxylate (9170)........................ II
Benzoylecgonine (9180)...................... II
Hydrocodone (9193).......................... II
Meperidine (9230)........................... II
Methadone (9250)............................ II
Methadone-intermediate (9254)............... II
Dextropropoxyphene, bulk (non-dosage forms) II
(9273).
Morphine (9300)............................. II
Thebaine (9333)............................. II
Opium extracts (9610)....................... II
Opium fluid extract (9620).................. II
Opium tincture (9630)....................... II
Opium powdered (9639)....................... II
Opium granulated (9640)..................... II
Levo-alphacetylmethadol (9648).............. II
Oxymorphone (9652).......................... II
Alfentanil (9737)........................... II
Sufentanil (9740)........................... II
Fentanyl (9801)............................. II
------------------------------------------------------------------------
Any other such applicant and any person who is presently registered
with DEA to manufacture such substances may file comments or objections
to the issuance of the proposed registration.
Any such comments or objections may be addressed, in quintuplicate,
to the Acting Deputy Assistant Administrator, Office of Diversion
Control, Drug Enforcement Administration, United States Department of
Justice, Washington, D.C. 20537, Attention: DEA Federal Register
Representative (CCR), and must be filed no later than August 12, 1997.
Dated: May 7, 1997.
Terrance W. Woodworth,
Acting Deputy Assistant Administrator, Office of Diversion Control,
Drug Enforcement Administration.
[FR Doc. 97-15455 Filed 6-12-97; 8:45 am]
BILLING CODE 4410-09-M